Literature DB >> 16825922

St. John's wort and the treatment of mild to moderate depression: a systematic review.

Kimberly Clement1, Catherine R Covertson, Mary Jane Johnson, Karen Dearing.   

Abstract

A systematic review of randomized controlled trials was conducted to determine the efficacy of St. John's Wort (SJW) in the treatment of mild to moderate depression. The Boyak and Lookinland Methodological Quality Index was used to evaluate the studies. Despite methodological concerns, all studies demonstrated a significant drop in the Hamilton Depression Rating Scale scores for clients taking SJW compared with placebo or pharmaceutical antidepressants. Practitioners may find SJW a viable complementary treatment alternative to traditional medical treatment. The results should encourage further research to validate these findings and seek the most appropriate preparations and dosing for this popular herb.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16825922     DOI: 10.1097/00004650-200607000-00008

Source DB:  PubMed          Journal:  Holist Nurs Pract        ISSN: 0887-9311            Impact factor:   1.000


  7 in total

1.  Hypericin prolongs action potential duration in hippocampal neurons by acting on K+ channels.

Authors:  Y Wang; X Shi; Z Qi
Journal:  Br J Pharmacol       Date:  2010-03-02       Impact factor: 8.739

2.  The efficacy of Hypericum perforatum (St John's wort) for the treatment of premenstrual syndrome: a randomized, double-blind, placebo-controlled trial.

Authors:  Sarah Canning; Mitch Waterman; Nic Orsi; Julie Ayres; Nigel Simpson; Louise Dye
Journal:  CNS Drugs       Date:  2010-03       Impact factor: 5.749

Review 3.  Herb-drug interactions with St John's wort (Hypericum perforatum): an update on clinical observations.

Authors:  Francesca Borrelli; Angelo A Izzo
Journal:  AAPS J       Date:  2009-10-27       Impact factor: 4.009

Review 4.  St. John's wort: role of active compounds for its mechanism of action and efficacy.

Authors:  Veronika Butterweck; Mathias Schmidt
Journal:  Wien Med Wochenschr       Date:  2007

5.  Results of a Pilot Randomized Placebo-Controlled Trial in Primary and Secondary Raynaud's Phenomenon with St. John's Wort: Detecting Changes in Angiogenic Cytokines When RP Improves.

Authors:  Déanne Malenfant; Kelly Summers; Shannon Seney; Donna McBain; Lisa Petrlich; Sharon Watson; Louise Vanderhoek; Nooshin Samadi; Ashley Bonner; Janet Pope
Journal:  ISRN Rheumatol       Date:  2011-09-12

6.  Efficacy of Hypericum extract WS(®) 5570 compared with paroxetine in patients with a moderate major depressive episode - a subgroup analysis.

Authors:  Erich Seifritz; Martin Hatzinger; Edith Holsboer-Trachsler
Journal:  Int J Psychiatry Clin Pract       Date:  2016-05-10       Impact factor: 1.812

Review 7.  Antiproliferative Effects of St. John's Wort, Its Derivatives, and Other Hypericum Species in Hematologic Malignancies.

Authors:  Alessandro Allegra; Alessandro Tonacci; Elvira Ventura Spagnolo; Caterina Musolino; Sebastiano Gangemi
Journal:  Int J Mol Sci       Date:  2020-12-25       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.